Work with thought leaders and academic experts in immunology allergy

Companies can benefit from working with Immunology and Allergy experts in several ways. These experts can provide valuable insights and knowledge to enhance research and development efforts. They can help in the development of innovative solutions and treatments for allergies and immune-related disorders. Collaborating with these experts can also lead to the discovery of new diagnostic tools and technologies. Additionally, companies can gain a competitive edge by leveraging the expertise of Immunology and Allergy researchers to stay ahead in the market.

Experts on NotedSource with backgrounds in immunology allergy include Regan Hamel, Jeffrey Townsend, Jo Boaler, Adrienne Lucas, Tensie Whelan, Marina Baretti, Miguel Ramirez, Andrea Guerrero, Abiodun Adewuya, Fadhel Kaboub, Chloe Goldbach, Ph.D., Orgul Ozturk, Gianfranco Santovito, Almabrok Essa, andrea bazzani, Mehrdad Sheikhvatan, Ernesto Lowy, Nicolas Collao, and John Joe.

Adrienne Lucas

Professsor and Department Chair of Economics, University of Delaware | Research Associate, NBER
Most Relevant Research Interests
Other Research Interests (26)
development economics
education economics
health economics
And 21 more
Adrienne Lucas is a professor of economics in the Alfred Lerner College of Business and Economics at the University of Delaware, a research associate of the National Bureau of Economic Research (NBER), a faculty affiliate of the Abdul Latif Jameel Poverty Action Lab (J-PAL), non-resident fellow at the Center for Global Development (CGD) and a research network member of Innovations for Poverty Action (IPA). She is a development economist specializing in the economics of education and disease. Her current research focuses on the importance of information in school choice decisions, using existing school system personnel and resources to increase student learning, and external validity across contexts. Lucas has published research on malaria, free primary education, HIV/AIDS, secondary school choice, the return to school quality, teacher incentives and improving early primary school literacy. Prior to joining the University of Delaware, she was an assistant professor of economics at Wellesley College. She received her Ph.D. and A.M. in economics from Brown University and her B.A. in economics from Wesleyan University. Watch Professor Lucas explain her work on the [intergenerational effects of HIV](, [improving student learning in existing schooling systems]( and the importance of [school leaders](

Marina Baretti

Baltimore, Maryland, United States of America
I am a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions.
Most Relevant Research Interests
Other Research Interests (20)
Pharmacology (medical)
And 15 more
Throughout my training, I have been focused toward my ultimate goal of becoming a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions. My clinical research is centered on the development of novel agents in GI cancers, with particular interest in combinatorial approaches of epigenetic therapies and immunotherapies combinations. I ran the first phase II study of combination epigenetic therapy and immunotherapy in advanced pancreatic adenocarcinoma and cholangiocarcinoma, working with a collaborative team that incorporates leading experts in cancer immunology, epigenetics and drug development. I was awarded the 2018 ASCO Conquer Cancer Foundation Young Investigator Award for this project.  Together with Dr. Yarchoan, we are running a clinical trial of a novel neoantigen-specific vaccine in combination with immune checkpoint inhibitors for advanced fibrolamellar carcinoma (FLC) (NCT04248569). My laboratory focus has been on developing and validating a preclinical mouse model of FLC to investigate mechanisms underlying FLC pathogenesis, and will become a critical tool for investigating novel therapeutic strategies in FLC.

Miguel Ramirez

Ward S. Curran Distinguished Professor of Economics, Trinity College
Most Relevant Research Interests
Other Research Interests (62)
Foreign Direct Investment
Latin American Economics
Public investment
Marxian economics.
And 57 more
Professor Ramirez is a native of Chile and a naturalized U.S. citizen since 1990. He received his Ph.D. in economics from the University of Illinois at Urbana-Champaign in 1984 and has been at Trinity College since 1985. He has held visiting positions at the University of Illinois at Champaign-Urbana (Summer 1991 and 1992), Haverford College (Spring 1992), Vanderbilt University (Spring 1999), and Yale University (Spring 2006). His teaching interests are primarily in the areas of Latin American economic development and international finance and open economy macroeconomics. At the College he usually offers Latin American economic development and Structural Reform in Latin America during the fall term, while international finance and open economy macroeconomics is taught during the spring term. He also teaches a course in Time-Series Analysis every other spring term, with particular emphasis on unit root and cointegration analysis, error correction modeling, and forecasting. Insofar as his research is concerned, it is primarily dedicated to analyzing the challenges and opportunities that Latin American nations face as they attempt to stabilize and reform their economies in an increasingly globalized world. In particular, his work has reviewed and analyzed the impact of IMF-sponsored adjustment and stabilization measures in Argentina, Chile, and Mexico, as well as the mixed success of structural reform programs such as privatization of state-owned firms, deregulation of economic activity, and liberalization of trade and finance. His research has also focused on the economic and institutional determinants of foreign direct investment in Argentina, Chile, and Mexico, as well as the impact of these flows on private capital formation and labor productivity growth in Latin America. Another important focus of his work in recent years has been the growing role of remittance flows in financing private investment spending and boosting economic growth in countries such as Ecuador, the Dominican Republic, El Salvador, Jamaica, and Mexico. Finally, he has published work in the history of economic thought relating to Marx's important analysis of wages and cyclical crises, his theory of absolute and differential ground rent, his analysis of the falling rate of profit, Marx's controversial writings on the so-called Asiatic mode of production, and his conception of capital as a social process.

Example immunology allergy projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on immunology allergy?

Development of Allergy Treatment

An Immunology and Allergy expert can collaborate with a pharmaceutical company to develop a new and effective treatment for allergies. This collaboration can involve conducting clinical trials, identifying novel therapeutic targets, and optimizing drug delivery methods.

Research on Autoimmune Diseases

Companies in the healthcare industry can collaborate with Immunology and Allergy researchers to study autoimmune diseases. This research can lead to the development of targeted therapies and personalized medicine approaches for patients with autoimmune disorders.

Vaccine Development

Immunology and Allergy experts can contribute to the development of vaccines for various diseases. Their knowledge of the immune system and allergens can help in designing effective vaccines and understanding immune responses to vaccination.

Diagnostic Tools for Allergies

Collaborating with Immunology and Allergy researchers can result in the development of advanced diagnostic tools for allergies. These tools can aid in accurate diagnosis, allergen identification, and personalized treatment plans for patients.

Drug Discovery and Testing

Pharmaceutical companies can collaborate with Immunology and Allergy experts to discover and test new drugs. These experts can provide valuable insights into the immune system's role in diseases and help in identifying potential drug targets.